In their respective positions dedicated
Release time:
2021-02-10
Be conscientious in their respective positions
Group Company's 2020 Innovation Expert Wu Lihua
of Guizhou Huangping Jianfeng Cement Company Looking back on our work in the past year, we have only been conscientious in our respective positions, contributing our meager strength to the cement industry of Jianfeng and doing some things that grass-roots employees should do.
2020 , I have been engaged in mechanical and electrical management in Huangping Jianfeng, and have experienced the whole process from construction to production of the company. Communicate with the design institute many times from the design to optimize the operation process and facilitate on-site operation and communication. Some control cabinets communicate with DCS system by DP communication, thus saving investment cost. Point-to-point communication is adopted between preheater and kiln head instrument, which is convenient for fault inspection and analysis. Due to the tight time limit for ignition of kiln system, some DCS optical cables try to weld themselves to make better preparations for debugging, spot and debug the equipment in advance; The pulverized coal scale and raw meal scale are calibrated online, and the central control operator can calibrate and calibrate directly on the computer. There is also a ClO2 generator for the water treatment system, which automatically controls the water level. Constant pressure control of domestic water pump; One-key start is adopted for the packaging and loading belt, and sound and light alarm is used to transmit information on the first and second floors, thus improving the packaging and shipping speed.
Today's results are achieved because we work and live in the great team of Spikes. During the commissioning of waste heat power generation, I received strong support from Feng Junwen, Shi Zhangliang, Chen Jun and others. Thanks to my colleagues, your love and dedication, and your selfless dedication to work have inspired me, inspired me, and spurred me all the time. At the same time, I would also like to thank the company leaders for their concern, correct decision-making and good team atmosphere. However, we must also be aware of our own shortcomings. The task of escorting production is very arduous. We will work harder to enrich our knowledge in the future. We are still far from the company's requirements. Only by deepening our professional knowledge can we continuously innovate and better complete our work, make our technological process more optimized and scientific, and make our equipment and electrical operation more normal and reliable.
Heaven rewards hard work, learning is endless, let us unite, invigorate our spirits, work hard, contribute to the creation of a century-old peak, and contribute our own strength. (According to Wu Lihua's speech at the group company's summary commendation meeting)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page